Please login to the form below

Not currently logged in
Email:
Password:

ViiV Healthcare

This page shows the latest ViiV Healthcare news and features for those working in and with pharma, biotech and healthcare.

J&J pledges $500m investment into HIV and tuberculosis R&D

J&J pledges $500m investment into HIV and tuberculosis R&D

J&J is also  partnered with GlaxoSmithKline subsidiary ViiV Healthcare on a long-acting injectable two-drug regimen for the treatment of HIV.

Latest news

  • ViiV builds case for switching to its two-drug HIV combinations ViiV builds case for switching to its two-drug HIV combinations

    Taking aim at rival Biktarvy. ViiV Healthcare says it has data that shows people with HIV can safely switch from Gilead's three-drug therapies to one of its two-drug ... Injectable option. Meanwhile, ViiV also had an update this week on another drug

  • ViiV bags EU okay for new two-drug HIV therapy ViiV bags EU okay for new two-drug HIV therapy

    Rivals Gilead's Biktarvy. ViiV Healthcare now has approval on both sides of the Atlantic for two-drug HIV therapy Dovato after a green light from the EMA. ... The challenge for ViiV is to convince patients and prescribers of that benefit.

  • McCann’s Breath of Life diagnostic wins Cannes Lion prize McCann’s Breath of Life diagnostic wins Cannes Lion prize

    The annual awards held in the south of France have become a must-attend fixture in the calendar for advertising and communications creatives across many different sectors, including healthcare and pharma. ... These included two winners from the UK –

  • GSK’s says depot HIV injection works over three years GSK’s says depot HIV injection works over three years

    doing group and 83% of the four-week group after 160 weeks of treatment, with “good overall tolerability”, according to GSK’s ViiV Healthcare unit. ... dominant player, but has been losing market share to ViiV over the last few years.

  • Gilead and ViiV among winners at PM Society Digital Awards Gilead and ViiV among winners at PM Society Digital Awards

    First 'Pharma Digital Partner' award presented. The continuing development of digital communication in pharma and healthcare was highlighted last night at the PM Society Digital Awards in London. ... Meanwhile ViiV Healthcare, Teva and Celgene all took a

More from news
Approximately 21 fully matching, plus 56 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 15 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you in the world of the patient...

Latest intelligence

What is changing in cardiovascular disease care?
Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma...
PANDAS/PANS Awareness: A parent’s story
To help raise awareness of these often underdiagnosed diseases, Jon Hallows, Joint MD at Porterhouse shares his own experience as a parent of a son recently diagnosed with PANDAS...
Iskra Reic
Leading AstraZeneca’s return to growth in Europe
PME talks to Iskra Reic, the company’s head of Europe and Canada...

Infographics